D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 52 Citations 8,839 173 World Ranking 1937 National Ranking 11

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Virus
  • Disease

Cheryl Cohen spends much of her time researching Virology, Incidence, Pediatrics, Epidemiology and Pandemic. Her Virology research incorporates themes from Infant newborn and Respiratory system. The Incidence study combines topics in areas such as Meningitis, Immunology, Pneumonia and Risk factor.

The various areas that Cheryl Cohen examines in her Pediatrics study include Rotavirus vaccine, Clinical endpoint, Case fatality rate, Pneumococcal conjugate vaccine and Child mortality. Her study in Epidemiology is interdisciplinary in nature, drawing from both Disease and Outbreak. As part of one scientific family, she deals mainly with the area of Disease burden, narrowing it down to issues related to the Young adult, and often Public health.

Her most cited work include:

  • Estimates of global seasonal influenza-associated respiratory mortality: a modelling study (799 citations)
  • Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. (727 citations)
  • Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. (727 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Virology, Vaccination, Pediatrics, Immunology and Epidemiology. Her work on Virus, Influenza A virus, Influenza A virus subtype H5N1 and Outbreak as part of general Virology research is often related to Human mortality from H5N1, thus linking different fields of science. The study incorporates disciplines such as Pneumococcal conjugate vaccine, Disease burden and Immunization in addition to Pediatrics.

Her Immunology research incorporates elements of Young adult, Internal medicine and Serostatus, Acquired immunodeficiency syndrome. Her Epidemiology research is multidisciplinary, incorporating perspectives in Public health, Incidence and Disease. Her Incidence research is multidisciplinary, incorporating elements of Logistic regression, Risk factor and Pneumonia.

She most often published in these fields:

  • Virology (39.93%)
  • Vaccination (37.46%)
  • Pediatrics (33.92%)

What were the highlights of her more recent work (between 2019-2021)?

  • Vaccination (37.46%)
  • Incidence (25.80%)
  • Pneumonia (17.31%)

In recent papers she was focusing on the following fields of study:

Cheryl Cohen mainly investigates Vaccination, Incidence, Pneumonia, Epidemiology and Transmission. Cheryl Cohen has included themes like Carriage, Pneumococcal conjugate vaccine, Cohort study and Meningococcal carriage in her Vaccination study. Her Incidence study combines topics from a wide range of disciplines, such as Human metapneumovirus, Pediatrics, Young infants and Logistic regression.

Her research links Serotype with Pediatrics. She combines subjects such as Family medicine and Confidence interval with her study of Epidemiology. Her Transmission research integrates issues from Influenza prevention, Disease burden and Environmental health.

Between 2019 and 2021, her most popular works were:

  • SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. (177 citations)
  • SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. (177 citations)
  • SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma (82 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Disease

Cheryl Cohen mainly focuses on Severe acute respiratory syndrome coronavirus 2, Virology, Incidence, Coronavirus and Tuberculosis. Her study in the fields of 2019-20 coronavirus outbreak, Vaccination and Transmission under the domain of Virology overlaps with other disciplines such as Risk assessment and Seasonal influenza. Her studies deal with areas such as Mortality rate and Logistic regression as well as Incidence.

Her research integrates issues of Spike Protein and Convalescent plasma in her study of Coronavirus. Her biological study spans a wide range of topics, including Hazard ratio, Standardized mortality ratio, Confidence interval, Attributable risk and Confounding. Cheryl Cohen is involved in the study of Antibody that focuses on Monoclonal antibody in particular.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.

Ting Shi;David A. McAllister;Katherine L. O'Brien;Eric A. F. Simoes.
The Lancet (2017)

1113 Citations

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

A Danielle Iuliano;Katherine M Roguski;Howard H Chang;David J Muscatello.
The Lancet (2017)

1017 Citations

Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis

Harish Nair;Harish Nair;Eric Af Simões;Igor Rudan;Bradford D Gessner.
The Lancet (2013)

628 Citations

Effects of vaccination on invasive pneumococcal disease in South Africa.

Anne von Gottberg;Linda de Gouveia;Stefano Tempia;Vanessa Quan.
The New England Journal of Medicine (2014)

309 Citations

Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

Cheryl Cohen;Joanne M. White;Emma J. Savage;Judith R. Glynn.
Emerging Infectious Diseases (2007)

259 Citations

Increased Prevalence of Severe Malaria in HIV-Infected Adults in South Africa

Cheryl Cohen;Alan Karstaedt;John Frean;Juno Thomas.
Clinical Infectious Diseases (2005)

219 Citations

Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases.

Brett N. Archer;Brett N. Archer;Cheryl Cohen;Cheryl Cohen;Dhamari Naidoo;J. Thomas;J. Thomas.
Eurosurveillance (2009)

192 Citations

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.

Constantinos Kurt Wibmer;Frances Ayres;Tandile Hermanus;Mashudu Madzivhandila.
Nature Medicine (2021)

177 Citations

Respiratory Viral Coinfections Identified by a 10-Plex Real-Time Reverse-Transcription Polymerase Chain Reaction Assay in Patients Hospitalized With Severe Acute Respiratory Illness—South Africa, 2009–2010

Marthi A Pretorius;Shabir A. Madhi;Shabir A. Madhi;Cheryl Cohen;Dhamari Naidoo.
The Journal of Infectious Diseases (2012)

170 Citations

High Nasopharyngeal Pneumococcal Density, Increased by Viral Coinfection, Is Associated With Invasive Pneumococcal Pneumonia

Nicole Wolter;Stefano Tempia;Cheryl Cohen;Shabir A. Madhi.
The Journal of Infectious Diseases (2014)

144 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Cheryl Cohen

Shabir A. Madhi

Shabir A. Madhi

University of the Witwatersrand

Publications: 145

Keith P. Klugman

Keith P. Klugman

Bill & Melinda Gates Foundation

Publications: 82

Robert S. Heyderman

Robert S. Heyderman

University College London

Publications: 63

Neil French

Neil French

University of Liverpool

Publications: 54

Martin Antonio

Martin Antonio

University of London

Publications: 46

Umesh D. Parashar

Umesh D. Parashar

Centers for Disease Control and Prevention

Publications: 42

Eric A. F. Simões

Eric A. F. Simões

University of Colorado Denver

Publications: 41

Clare L. Cutland

Clare L. Cutland

University of the Witwatersrand

Publications: 40

Marc-Alain Widdowson

Marc-Alain Widdowson

Centers for Disease Control and Prevention

Publications: 38

Benjamin J. Cowling

Benjamin J. Cowling

University of Hong Kong

Publications: 37

Asuncion Mejias

Asuncion Mejias

The Ohio State University

Publications: 36

Harry Campbell

Harry Campbell

University of Edinburgh

Publications: 36

J. Anthony G. Scott

J. Anthony G. Scott

University of London

Publications: 35

Louis Bont

Louis Bont

Utrecht University

Publications: 34

Robert F. Breiman

Robert F. Breiman

Emory University

Publications: 31

Heather J. Zar

Heather J. Zar

University of Cape Town

Publications: 30

Trending Scientists

Dwarikanath Mahapatra

Dwarikanath Mahapatra

Inception Institute of Artificial Intelligence

James R. Fienup

James R. Fienup

University of Rochester

Paul Drzaic

Paul Drzaic

E Ink (South Korea)

George M. Sheldrick

George M. Sheldrick

University of Göttingen

Jean Paul Metzger

Jean Paul Metzger

Universidade de São Paulo

Jules Janick

Jules Janick

Purdue University West Lafayette

David B. Knaff

David B. Knaff

Texas Tech University

Joseph L. Melnick

Joseph L. Melnick

Baylor University

Maria Concetta Morrone

Maria Concetta Morrone

University of Pisa

Klaus G. Reymann

Klaus G. Reymann

Leibniz Institute for Neurobiology

Hannu Tiitinen

Hannu Tiitinen

Aalto University

Hannes Vogel

Hannes Vogel

Stanford University

Andreas Unterberg

Andreas Unterberg

Heidelberg University

Laurence M. Grummer-Strawn

Laurence M. Grummer-Strawn

Centers for Disease Control and Prevention

Martin Post

Martin Post

University of Toronto

John B. Casterline

John B. Casterline

The Ohio State University

Something went wrong. Please try again later.